Foreword |
|
ix | |
Contributors |
|
xi | |
Preface |
|
xv | |
Acknowledgements |
|
xvii | |
Part One: The development of pharmacy practice |
|
|
The historical context of pharmacy |
|
|
3 | (28) |
|
|
|
31 | (18) |
|
|
|
Primary and secondary care pharmacy |
|
|
49 | (12) |
|
Part Two: International dimensions of pharmacy practice |
|
|
Community pharmacy in Europe |
|
|
61 | (10) |
|
|
Pharmacy in North America |
|
|
71 | (10) |
|
|
|
Pharmacy in developing countries |
|
|
81 | (24) |
|
Part Three: Health, illness and medicines use |
|
|
The social context of health and illness |
|
|
105 | (18) |
|
|
Inequalities in Health and health care |
|
|
123 | (16) |
|
|
The supply and consumption of over the counter drugs |
|
|
139 | (12) |
|
|
|
151 | (14) |
|
|
|
|
Compliance, adherence and concordance |
|
|
165 | (22) |
|
Part Four: Professional practice |
|
|
|
187 | (16) |
|
|
|
Professional judgement and ethical dilemmas |
|
|
203 | (24) |
|
|
|
227 | (22) |
|
|
|
Pharmacists and the multidisciplinary health care team |
|
|
249 | (24) |
|
Part Five: Meeting the pharmaceutical care needs of specific populations |
|
|
|
273 | (16) |
|
|
|
|
|
289 | (12) |
|
|
|
|
Pregnancy and breastfeeding mothers |
|
|
301 | (12) |
|
Lolkje de Jong-van den Berg |
|
|
|
The elderly and their carers |
|
|
313 | (16) |
|
|
People with mental health problems |
|
|
329 | (16) |
|
|
|
345 | (22) |
|
|
Part Six: Measuring and regulating medicines use |
|
|
Pharmacovigilance and pharmacoepidemiology |
|
|
367 | (26) |
|
|
Lolkje de Jong-van den Berg |
|
|
|
393 | (18) |
|
Part Seven: Research methods |
|
|
Measurements of health and illness |
|
|
411 | (22) |
|
|
|
433 | (24) |
|
|
|
|
457 | (16) |
|
|
|
473 | (12) |
|
|
Analysing qualitative data |
|
|
485 | (8) |
|
|
|
|
|
493 | (16) |
|
|
Evaluating community pharmacy services |
|
|
509 | (14) |
|
|
Evaluating hospital pharmacy services |
|
|
523 | (14) |
|
|
|
Professional audit and clinical governance |
|
|
537 | |
|